Principal Financial Group Inc Castle Biosciences Inc Transaction History
Principal Financial Group Inc
- $172 Billion
- Q4 2024
A detailed history of Principal Financial Group Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 1,435,665 shares of CSTL stock, worth $30.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,435,665Holding current value
$30.3 Million% of portfolio
0.02%Shares
19 transactions
Others Institutions Holding CSTL
# of Institutions
207Shares Held
25.8MCall Options Held
128KPut Options Held
35.4K-
Black Rock Inc. New York, NY3.04MShares$64.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$38.7 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.8MShares$38 Million0.24% of portfolio
-
Dimensional Fund Advisors LP Austin, TX999KShares$21.1 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il835KShares$17.6 Million0.0% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $556M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...